OPXIL IMP® 500 mg
Manufacturer
Branch 3 - Imexpharm Corporation in Binh Duong Province
Applicant company
Imexpharm Pharmaceutical Joint Stock Company
Active ingredient
Cephalexin (as cephalexin monohydrat compacted)
Content
500 mg
Shelf life
36 months
Dosage Form
Hard capsule
Package
Box of 10 blisters x 10 hard capsules
Visa Number
893110809624
Issuing Date
23/08/2024
Therapeutic area
Antibiotics
Indication
Opxil IMP 500mg is indicated in the treatment of the following infections due to susceptible micro-organisms:
- Respiratory tract infections.
- Otitis media.
- Skin and soft tissue infections.
- Bone and joint infections.
- Genito-urinary tract infections, including acute prostatitis.
- Dental infections.
Dosage
Adults:
The adult dosage ranges from 1-4 g daily (2 – 8 tablets/ day) in divided doses; most infections will respond to a dosage of 500 mg (1 tablet) every 8 hours.
For skin and soft tissue infections, streptococcal pharyngitis, and mild, uncomplicated urinary tract infections, the usual dosage is 500 mg every 12 hours.
For more severe infections or those caused by less susceptible organisms, larger doses may be needed. If daily doses of cefalexin greater than 4 g are required, parenteral cephalosporins, in appropriate doses, should be considered.
Elderly patients and Patients with impaired renal function
The recommended dose for adults should be used in elderly patients. Dosage should be reduced if renal function is severely impaired. Dosage should not exceed 500 mg/ day (1 tablet) if glomerular filtration rate <10ml/min.
Children 5 years and older:
- For severe infections: 500 mg (1 tablet) every 8 hours.
- For infections caused by beta-hemolytic streptococci, treatment should be continued for at least 10 days.
- The strength and dosage form of Opxil IMP 500 mg hard capsules are not suitable for use in children under 5 years of age or for the treatment of mild to moderate infections in children.
Contact